Vesna
Vesna Aleksandrovic-Bondzic, Hamburg DE
Patent application number | Description | Published |
---|---|---|
20130203866 | Thickened Polymer - The invention relates to a polymer which can be obtained by radical emulsion polymerization of at least one acidic vinyl monomer or salt thereof, at least one non-ionic vinyl monomer, in particular preferably a hydrophobic non-ionic vinyl monomer, at least one monomer containing an unsaturated terminal group and a polyoxyalkyene portion, at least one crosslinking monomer, optionally a protective colloid, and is characterized in that the polymerization is controlled such that the gelling effect occurs at least at times, which is achieved by the monomer addition (dosing time) taking place for 40 minutes, particularly preferably for 30 minutes. | 08-08-2013 |
Vesna Anusic, Mississauga CA
Patent application number | Description | Published |
---|---|---|
20100315972 | DISCOVERY AND REDISCOVERY PROTOCOL METHOD AND SYSTEM - A management station discovers agent devices connected to a network by broadcasting discovery messages having a session number and waiting for discovery acknowledge unicast messages from at least some of the discovery aware agent devices connected to the network. The management station receives the discovery acknowledge unicast messages from the agent devices and each message comprises the session number and an address uniquely identifying the agent device sending the discovery acknowledge unicast message. The management station then sends a unicast registration message having a sequence number based on the session number of the discovery message. At that point, the agent device will be registered permitting further communication to the registered discovery aware agent device. The management station will send, periodically, rediscovery messages having the same session number as the discovery message. The discovery aware agent devices connected to the network which have not previously responded to a discovery or rediscovery message having the same session number or have not received a registration message with a sequence number related to the session number will respond to subsequent rediscovery messages. The agent devices will not respond to subsequent rediscovery messages if the agent device has previously received a unicast registration message with a sequence number related to the session number of the multicast discovery message or the subsequent multicast rediscovery message. | 12-16-2010 |
Vesna Biberovic, Aulnay-Sous-Bois FR
Patent application number | Description | Published |
---|---|---|
20110201573 | MIXTURES OF POLYSACCHARIDES DERIVED FROM HEPARIN, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM - The present invention relates to mixtures of polysaccharides derived from heparin having a mean molecular weight of 1500 to 3000 Daltons and an anti-Xa/anti-IIa ratio greater than 30, their method of preparation and pharmaceutical compositions containing them. | 08-18-2011 |
20110212915 | MIXTURES OF POLYSACCHARIDES DERIVED FROM HEPARIN, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM - The present invention relates to mixtures of polysaccharides derived from heparin having a mean molecular weight of 1500 to 3000 Daltons and an anti-Xa/anti-IIa ratio greater than 30, their method of preparation and pharmaceutical compositions containing them. | 09-01-2011 |
Vesna Borjanovic, Cary, NC US
Patent application number | Description | Published |
---|---|---|
20100181534 | Enhancement of photoluminescence of nanodiamond particles - Photoluminescent nanodiamond particles of dynamic synthesis have enhanced photoluminescent properties produced as a result of minimizing the nitrogen content of impurities or imperfections in the nanodiamond lattice and by location of photoluminescent structures on the outer surface of the nanodiamond particles. This inhibits suppression (i.e. inactivity) of emission and enhances the intensity of the emission. This abstract is not to be considered limiting, since other embodiments may deviate from the features described in this abstract. | 07-22-2010 |
Vesna Erakovic, Rijeka HR
Patent application number | Description | Published |
---|---|---|
20080200403 | 9A-Carbamoyl and Thiocarbamoyl Azalides with Anti-Inflammatory Activity - The use of semi-synthetic 9a-carbamoyl or thiocarbamoyl azalides for the treatment and prevention of inflammatory diseases and conditions in humans and animals. More particularly, the invention relates to the use of 15-membered azalides having at the 9a-position carbamoyl or thiocarbamoyl group, and their pharmaceutically acceptable derivatives for the treatment and prevention of inflammatory diseases and conditions in humans and animals. | 08-21-2008 |
20080221046 | Macrolides With Anti-Inflammatory Activity - The present invention relates to novel semi-synthetic macrolides having anti-inflammatory activity. More particularly, the invention relates to 14- and 15-membered macrolides substituted at the 4″ position, to their pharmaceutically acceptable derivatives, to processes and intermediates for their preparation, to pharmaceutical compositions containing them and to their activity and use in the treatment of inflammatory diseases and conditions in humans and animals, especially those diseases associated with excessive secretion of TNF-α, IL-1, IL-8, IL-2 or IL-5; and/or inhibitor of excessive lymphocyte proliferation; and/or excessive granulocyte degranulation. | 09-11-2008 |
Vesna Erakovic Haber, Rijeka HR
Patent application number | Description | Published |
---|---|---|
20120058963 | Macrolides with Anti-Inflammatory Activity - The present invention relates to novel semi-synthetic macrolides having anti-inflammatory activity. More particularly, the invention relates to 14- and 15-membered macrolides substituted at the 4″ position, to their pharmaceutically acceptable derivatives, to processes and intermediates for their preparation, to pharmaceutical compositions containing them and to their activity and use in the treatment of inflammatory diseases and conditions in humans and animals, especially those diseases associated with excessive secretion of TNF-α, IL-1, IL-8, IL-2 or IL-5; and/or inhibitor of excessive lymphocyte proliferation; and/or excessive granulocyte degranulation. | 03-08-2012 |
Vesna Gavrilovic, San Jose, CA US
Patent application number | Description | Published |
---|---|---|
20090298125 | HALOHYDRIN DEHALOGENASES AND RELATED POLYNUCLEOTIDES - The present invention relates to novel halohydrin dehalogenase polypeptides and the polynucleotides that encode them. These polypeptides are useful in the production of 4-substituted-3-butyric acid derivatives and vicinal cyano, hydroxyl substituted carboxylic acid esters. The invention also provides related vectors, host cells and methods. | 12-03-2009 |
20100167345 | HALOHYDRIN DEHALOGENASES AND RELATED POLYNUCLEOTIDES - The present invention relates to novel halohydrin dehalogenase polypeptides and the polynucleotides that encode them. These polypeptides are useful in the production of 4-substituted-3-butyric acid derivatives and vicinal cyano, hydroxyl substituted carboxylic acid esters. The invention also provides related vectors, host cells and methods. | 07-01-2010 |
20120208259 | Halohydrin Dehalogenases and Related Polynucleotides - The present invention relates to novel halohydrin dehalogenase polypeptides and the polynucleotides that encode them. These polypeptides are useful in the production of 4-substituted-3-butyric acid derivatives and vicinal cyano, hydroxyl substituted carboxylic acid esters. The invention also provides related vectors, host cells and methods. | 08-16-2012 |
Vesna Jerkovic, Nivelles BE
Patent application number | Description | Published |
---|---|---|
20100166926 | SPENT HOP PRODUCTS, THEIR CONTENT IN STILBENES AND THEIR USE AS ANTIOXIDANT FOR COMESTIBLE PRODUCTION - A method of producing a comestible by adding spent hop material during the production of the comestible, wherein the stilbenes and flavanoids contained in the spent hop material act as quenchers of oxygen resulting in an improved flavor stability of the comestible, and wherein the surviving stilbenes present in the comestible provide additional anti-oxidative properties to the comestible, leading to health benefits for the consumer. | 07-01-2010 |
Vesna Katavic, Vancouver CA
Patent application number | Description | Published |
---|---|---|
20100122377 | LUNARIA ANNUA,CARDAMINE GRAECA AND TEESDALIA NUDICAULIS FAE GENES AND THEIR USE IN PRODUCING NERVONIC AND EICOSENOIC ACIDS IN SEED OILS - This invention relates to nucleic acid sequences coding for a | 05-13-2010 |
Vesna Kroselj, Sentjernej SL
Patent application number | Description | Published |
---|---|---|
20130190487 | PROCESS FOR THE PREPARATION OF EZETIMIBE AND DERIVATIVES THEREOF - The present invention relates to the method of preparing of ezetimibe and in particular to novel intermediates for its synthesis and an improved process for preparing such intermediates. Said intermediates may be obtained in high yields and purity in a fast and cost efficient manner. The present invention relates to a novel crystalline form of ezetimibe as well. | 07-25-2013 |
Vesna Kroselj, Novo Mesto SI
Patent application number | Description | Published |
---|---|---|
20130177652 | PHARMACEUTICAL ORAL DOSAGE FORMS COMPRISING DABIGATRAN ETEXILATE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS - The invention relates to pharmaceutical oral dosage forms of the active substance ethyl 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazole-5-carbonyl)-pyridin-2-yl-amino]-propionate (dabigatran etexilate) and the pharmacologically acceptable salts thereof, in particular dabigatran etexilate methanesulfonate. | 07-11-2013 |
Vesna Kroselj, Sentjernej SI
Patent application number | Description | Published |
---|---|---|
20080300233 | Pharmaceutical Composition Comprising Simvastatin and Ezetimibe - The present invention relates to the field of pharmaceutical technology and in particular to novel dosage forms of medicaments containing as active ingredients simvastatin and ezetimibe, or pharmaceutically acceptable salts thereof. The present pharmaceutical compositions are characterized in that the contact of the compositions with oxygen is substantially reduced, such as by coating the composition, providing a medicament useful for the treatment and prevention of atherosclerosis and related conditions, in an environment having an essentially reduced oxygen or humidity, respectively, content. | 12-04-2008 |
Vesna Radisic, Manhattan Beach, CA US
Patent application number | Description | Published |
---|---|---|
20110050371 | Monolithically integrated active electronic circuit and waveguide structure for terahertz frequencies - An electronic system. The electronic system includes a waveguide structure having a first waveguide-coupling point and a second waveguide-coupling point and an active electronic circuit having a first circuit-coupling point and a second circuit-coupling point. The second waveguide-coupling point is coupled to the first circuit-coupling point; the system is capable of receiving an input signal at the first waveguide-coupling point and transmitting an output signal at the second circuit-coupling point and/or receiving the input signal at the second circuit-coupling point and transmitting the output signal at the first waveguide-coupling point; the input signal and the output signal have frequencies in a terahertz frequency range; and the system is fabricated as a monolithic integrated structure having the waveguide structure fabricated by micromachining and the circuit fabricated monolithically. | 03-03-2011 |
20120313105 | UNIPOLAR DIODE WITH LOW TURN-ON VOLTAGE - A unipolar diode with low turn-on voltage includes a subcathode semiconductor layer, a low-doped, wide bandgap cathode semiconductor layer, and a high-doped, narrow bandgap anode semiconductor layer. A junction between the cathode layer and the anode layer creates an electron barrier in the conduction band, with the barrier configured to produce a low turn-on voltage for the diode. A unipolar diode with low turn-on voltage includes an n | 12-13-2012 |
Vesna Radojkovic, Suzhou CN
Patent application number | Description | Published |
---|---|---|
20120262343 | WIDEBAND ANTENNA AND METHODS - A wideband antenna for use portable radio devices, and methods for operating the same. In one embodiment, a monopole antenna is used within a laptop computing device. The antenna comprises a monopole radiator coupled to an auxiliary ground plane element, and is placed substantially outside of the footprint of the computer display ground plane. In one implementation, the auxiliary ground element is configured not to have electrical connections to the ground plane of the laptop. In another implementation, a solid state switch selectively connects an antenna parasitic element to the main ground thus enabling selective control of the antenna lower frequency operating band. | 10-18-2012 |
Vesna Rafaty, Dallas, TX US
Patent application number | Description | Published |
---|---|---|
20110182283 | Web-based, hosted, self-service outbound contact center utilizing speaker-independent interactive voice response and including enhanced IP telephony - Disclosed is an on demand, web-based, outbound contact center utilizing Voice over IP (VoIP) and speaker-independent voice recognition which automatically captures contact responses to question events in a pre-recorded, interactive voice call, the call launched by a user via a broadcast comprising a call sequence created by the user via a call center user interface comprising event add and logic add wizards, the call sequence comprising event prompts based on a user-generated script comprising message events and question events, the event prompts in the group consisting of voice recordings and text-to-speech inputs. | 07-28-2011 |
Vesna Skulj, Ljubljana SI
Patent application number | Description | Published |
---|---|---|
20120028949 | Rapidly Disintegrating Tablet - The present invention relates to rapidly disintegrating tablets intended to be used as orodispersible tablets or dispersible tablets. They are ingested either by dispersing directly in the mouth or in water. The tablets include silicified microsrystalline cellulose. They are especially suitable for antibiotics. These tablets are also suitable for use in pediatric patients in the age above 3 years. For pediatric patients under 3 years the same tablets can be used as dispersible tablets. Rapidly disintegrating tablets which contain amoxicillin and clavulanic acid are also described. | 02-02-2012 |
Vesna Sossi, Vancouver CA
Patent application number | Description | Published |
---|---|---|
20110002431 | METHOD FOR DIRECT PRODUCTION OF 99mTc - TECHNETIUM 99 METASTABLE FROM LOW ENERGY ACCELERATORS - Target, computer software and method for direct production of | 01-06-2011 |
Vesna Svetlicic, Zagreb HR
Patent application number | Description | Published |
---|---|---|
20090095643 | Amperometric Method And Apparatus For Measurement Of Soft Particles In Liquids By Analyzing The Adhesion Of These Particles To An Electrode - Method and apparatus for measurement and analysis of soft particles in liquids in the size range 1-500 μm represented by vesicles and living cells, liposomes and blood cells in particular, but also to diluted dispersions of oil droplets and other confined microparticles in liquids. The method is based on amperometric detection and analysis of single events of particle adhesion in raw samples, or after the concentration adjustment, by means of permanent record of time series of stochastic electrical signals in the real time. The detected new class of electrical signals is generated by adhesion causing the deformation, rupture and spreading of soft particles at mercury electrode in air saturated liquids. Information stored in one current pulse signal is: particle size, adhesion properties and electrode surface area occupied by the spread particle, which is characteristic for each class of particles. The current pulses, appear at irregular intervals due to the inherently stochastic nature of the I particle encounter with the electrode. The total pulse counts (N) recorded for a: fixed time interval (e.g. 100 seconds) is the measure of particle concentration; (C/particles L | 04-16-2009 |
Vesna Urosev, Mississauga CA
Patent application number | Description | Published |
---|---|---|
20140300643 | RESOLUTION INDEPENDENT CLIENT SIDE RENDERING - Exemplary embodiments involve a viewer application receiving input modifying a rendering attribute of electronic content. The viewer application modifies a view-to-image transformation matrix based on the input. The view-to-image transformation matrix is capable of converting resolution-based coordinates of the electronic content to a corresponding resolution-independent coordinates of the electronic content. The viewer application generates a view-to-resolution transformation matrix based on the view-to-image transformation matrix as modified. The viewer application renders updated electronic content generated by applying the view-to-resolution transformation matrix to the electronic content. | 10-09-2014 |
Vesna Zderic, Washington, DC US
Patent application number | Description | Published |
---|---|---|
20090112098 | THIN-PROFILE THERAPEUTIC ULTRASOUND APPLICATORS - An ultrasound therapy probe including a thin-profile therapy head for implementing therapeutic procedures in confined spaces. The thin-profile is achieved by incorporating a cooling fluid channel about a periphery of at least a portion of the housing. A therapy transducer is disposed in an inner volume of the housing, and fluid circulated through the peripheral cooling channel can be used to remove heat generated by the therapy transducer, without requiring bulky external cooling devices, such as balloons. The housing can include an acoustic lens portion, to enable the housing to be used with flat transducers and can also be configured to be used with concave transducers, and so that an acoustic lens is not required. Electrical connections can be made with conductors that extend through an elongate hollow handle. | 04-30-2009 |